Cargando…
Atezolizumab-associated Dermatomyositis in Advanced Small-cell Lung Carcinoma
Dermatomyositis is a rare immune-related adverse event caused by immune checkpoint inhibitors. We herein report a 75-year-old Japanese man with small-cell lung carcinoma who developed dermatomyositis after the administration of atezolizumab. He developed rashes on day 13 and myalgia and motor weakne...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Japanese Society of Internal Medicine
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502675/ https://www.ncbi.nlm.nih.gov/pubmed/33776010 http://dx.doi.org/10.2169/internalmedicine.6917-20 |